Capital International’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-23,744
Closed -$3.05M 158
2023
Q2
$3.05M Buy
23,744
+16
+0.1% +$1.94K 0.17% 122
2023
Q1
$2.76M Buy
23,728
+856
+4% +$95.8K 0.17% 131
2022
Q4
$2.59M Buy
22,872
+159
+0.7% +$17.5K 0.18% 127
2022
Q3
$1.83M Buy
22,713
+2,013
+10% +$170K 0.13% 136
2022
Q2
$1.54M Buy
20,700
+2,224
+12% +$203K 0.12% 133
2022
Q1
$2.36M Buy
18,476
+11,828
+178% +$1.29M 0.13% 130
2021
Q4
$892K Buy
+6,648
New +$955K 0.05% 152

Other funds holding DXCM

Capital International's DXCM Position: Q3 2023 in Review

Capital International sold out of DexCom (DXCM) in Q3 2023, closing a stake of 23,744 shares — an estimated $3.05M sold.

Capital International first reported a position in DXCM in Q4 2021 and held it in 7 quarters. The position peaked at $3.05M in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Capital International reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Capital International sold 23,744 DexCom shares in Q3 2023, an estimated $3.05M.
  • Capital International first reported a position in DexCom in Q4 2021 and held it in 7 quarters.
  • Capital International's DexCom position peaked at $3.05M in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Capital International's 13F filing for Q3 2023, filed 13 Nov 2023.